Current Environment: Production

Eba Hathout | Medical Services

Programs & Services

Languages

  • Arabic
  • English
  • French
  • Spanish

Eba Hathout | Education

Medical School

Faculty of Medicine, Kuwait University

Jabriya, Kuwait

Residency

Pediatrics

University of California at Irvine

Irvine, CA

Fellowship

Pediatric Endocrinology

University of California Los Angeles

Los Angeles, CA

Eba Hathout | Certifications

  • American Board of Pediatrics (Endocrinology)

Eba Hathout | Publications

  1. Partial hepatectomy improves the outcome of intraportal islet transplantation by promoting revascularization. Islets. 2012 Mar-Apr; 4(2):138-44. View Partial hepatectomy improves the outcome of intraportal islet transplantation by promoting revascularization. Abstract

  2. Nerve growth factor is associated with islet graft failure following intraportal transplantation. Islets. 2012 Jan-Feb; 4(1):24-31. View Nerve growth factor is associated with islet graft failure following intraportal transplantation. Abstract

  3. A pathway to insulin independence in newborns and infants with diabetes. J Perinatol. 2011 Aug; 31(8):567-70. View A pathway to insulin independence in newborns and infants with diabetes. Abstract

  4. Hyperbaric oxygen therapy improves early posttransplant islet function. Pediatr Diabetes. 2010 Nov; 11(7):471-8. View Hyperbaric oxygen therapy improves early posttransplant islet function. Abstract

  5. Bone marrow cell cotransplantation with islets improves their vascularization and function. Transplantation. 2010 Mar 27; 89(6):686-93. View Bone marrow cell cotransplantation with islets improves their vascularization and function. Abstract

  6. Correlation between angiogenesis and islet graft function in diabetic mice: magnetic resonance imaging assessment. J Hepatobiliary Pancreat Sci. 2010 Sep; 17(5):692-700. View Correlation between angiogenesis and islet graft function in diabetic mice: magnetic resonance imaging assessment. Abstract

  7. Bone marrow cells produce nerve growth factor and promote angiogenesis around transplanted islets. World J Gastroenterol. 2010 Mar 14; 16(10):1215-20. View Bone marrow cells produce nerve growth factor and promote angiogenesis around transplanted islets. Abstract

  8. Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. Islets. 2009 Nov; 1(3):249-255. View Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. Abstract

  9. Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. Islets. 2009 Nov-Dec; 1(3):249-55. View Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. Abstract

  10. Factors affecting islet graft embolization in the liver of diabetic mice. Islets. 2009 Jul-Aug; 1(1):26-33. View Factors affecting islet graft embolization in the liver of diabetic mice. Abstract

  11. Factors affecting islet graft embolization in the liver of diabetic mice. Islets. 2009 Jul 01; 1(1):26-33. View Factors affecting islet graft embolization in the liver of diabetic mice. Abstract

  12. MRI assessment of ischemic liver after intraportal islet transplantation. Transplantation. 2009 Mar 27; 87(6):825-30. View MRI assessment of ischemic liver after intraportal islet transplantation. Abstract

  13. Efficacy comparison between intraportal and subcapsular islet transplants in a murine diabetic model. Transplant Proc. 2009 Jan-Feb; 41(1):346-9. View Efficacy comparison between intraportal and subcapsular islet transplants in a murine diabetic model. Abstract

  14. In vivo imaging demonstrates a time-line for new vessel formation in islet transplantation. Pediatr Transplant. 2009 Nov; 13(7):892-7. View In vivo imaging demonstrates a time-line for new vessel formation in islet transplantation. Abstract

  15. Post-transplant diabetes mellitus in pediatric liver transplantation. Pediatr Transplant. 2009 Aug; 13(5):599-605. View Post-transplant diabetes mellitus in pediatric liver transplantation. Abstract

  16. In vivo magnetic resonance imaging of vascularization in islet transplantation. Transpl Int. 2007 Dec; 20(12):1059-65. View In vivo magnetic resonance imaging of vascularization in islet transplantation. Abstract

  17. Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Am J Transplant. 2006 Nov; 6(11):2636-43. View Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Abstract

  18. Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes. Diabetes Care. 2006 Jun; 29(6):1458. View Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes. Abstract

  19. Air pollution and type 1 diabetes in children. Pediatr Diabetes. 2006 Apr; 7(2):81-7. View Air pollution and type 1 diabetes in children. Abstract

  20. Cardiac allograft vasculopathy in pediatric heart transplant recipients. Transpl Int. 2006 Mar; 19(3):184-9. View Cardiac allograft vasculopathy in pediatric heart transplant recipients. Abstract

  21. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Transplantation. 2006 Feb 27; 81(4):519-24. View In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Abstract

  22. Beneficial effects of nerve growth factor on islet transplantation. Transplant Proc. 2005 Oct; 37(8):3490-2. View Beneficial effects of nerve growth factor on islet transplantation. Abstract

  23. Home use of the GlucoWatch G2 biographer in children with diabetes. Pediatrics. 2005 Mar; 115(3):662-6. View Home use of the GlucoWatch G2 biographer in children with diabetes. Abstract

  24. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes. 2004 Oct; 53(10):2713-8. View Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Abstract

  25. Growth after heart transplantation. Pediatr Transplant. 2004 Apr; 8(2):97-100. View Growth after heart transplantation. Abstract

  26. Familial juvenile autoimmune hypothyroidism, pituitary enlargement, obesity, and insulin resistance. Thyroid. 2004 Apr; 14(4):311-9. View Familial juvenile autoimmune hypothyroidism, pituitary enlargement, obesity, and insulin resistance. Abstract

  27. Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients. Am J Transplant. 2003 Aug; 3(8):994-8. View Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients. Abstract

  28. Islet transplant: an option for childhood diabetes? Arch Dis Child. 2003 Jul; 88(7):591-4. View Islet transplant: an option for childhood diabetes? Abstract

  29. Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. Pediatrics. 2003 Apr; 111(4 Pt 1):860-3. View Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. Abstract

  30. How should we interpret "real life" conditions. Pediatr Diabetes. 2003 Mar; 4(1):59. View How should we interpret "real life" conditions. Abstract

  31. Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes. Diabetes Technol Ther. 2003; 5(5):801-6. View Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes. Abstract

  32. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes. Diabetes Technol Ther. 2003; 5(2):175-81. View Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes. Abstract

  33. Role of exposure to air pollutants in the development of type 1 diabetes before and after 5 yr of age. Pediatr Diabetes. 2002 Dec; 3(4):184-8. View Role of exposure to air pollutants in the development of type 1 diabetes before and after 5 yr of age. Abstract

  34. Use of the GlucoWatch biographer in children and adolescents with diabetes. Pediatr Diabetes. 2002 Sep; 3(3):127-34. View Use of the GlucoWatch biographer in children and adolescents with diabetes. Abstract

  35. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics. 2001 Jun; 107(6):E102. View Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Abstract

  36. Diabetic autoimmunity in infants and pre-schoolers with type 1 diabetes. Pediatr Diabetes. 2000 Sep; 1(3):131-4. View Diabetic autoimmunity in infants and pre-schoolers with type 1 diabetes. Abstract

  37. Suprasellar dysplasia: a pediatric perspective. Clin Pediatr (Phila). 2000 Jan; 39(1):45-9. View Suprasellar dysplasia: a pediatric perspective. Abstract

  38. Changes in plasma leptin during the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 1999 Dec; 84(12):4545-8. View Changes in plasma leptin during the treatment of diabetic ketoacidosis. Abstract

  39. Normal growth despite GH, IGF-I and IGF-II deficiency. Growth Horm IGF Res. 1999 Aug; 9(4):272-7. View Normal growth despite GH, IGF-I and IGF-II deficiency. Abstract

  40. A case of hepatocyte nuclear factor-1 alpha diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea. Diabetes Care. 1999 May; 22(5):867-8. View A case of hepatocyte nuclear factor-1 alpha diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea. Abstract

  41. Association of terminal chromosome 1 deletion with sertoli cell-only syndrome. Am J Med Genet. 1998 Dec 04; 80(4):396-8. View Association of terminal chromosome 1 deletion with sertoli cell-only syndrome. Abstract

  42. Hemifacial microsomia and abnormal chromosome 22. Am J Med Genet. 1998 Feb 26; 76(1):71-3. View Hemifacial microsomia and abnormal chromosome 22. Abstract

  43. Absence of GLUT2 protein in near-term fetal rat pancreatic islets. Pancreas. 1997 Apr; 14(3):318-21. View Absence of GLUT2 protein in near-term fetal rat pancreatic islets. Abstract

BESbswy